In early January 2026, UBS upgraded Bristol-Myers Squibb after highlighting its broad drug pipeline, new clinical trial ...

Visteon (VC) shifts to AI-compute HPC platforms as Q3 margins stay strong; catalysts include SmartCore launch and China OEM ...

Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high ...

OXFORD, England, Jan. 6, 2026 /PRNewswire/ -- Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been ...

Andy Thorn joins the committee with more than 30 years in the BEMS industry, having held roles at Trend, Honeywell, and now Synapsys, where he became Managing Director in 2023. A long-time BCIA member ...

Amgen’s acquisition of Dark Blue Therapeutics adds a first-in-class leukemia program that aligns with the company’s growing ...

New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared to placebo in women during ...

Not everyone agrees on who is to blame for Kanpur’s decline. Even RSS-backed trade unions don’t rush to blame the striking ...

For the BCIA, 2025 has been a thoroughly successful and positive year. With more than 270 apprentices on its Level 4 Building ...

New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared to placebo in women during menopausal transition ageBrigham and Women's Hospital t ...

Advancing toward OEM readiness through advanced vehicle program evaluation; targets up to ~1,000 km EV range.LAS VEGAS, Jan. 6, 2026 /PRNewswire/ -- ...

ProLogium has entered a new phase of collaboration with Delta after signing an MoU to develop a next‑gen battery energy ...